AAAAAA

   
Results: 1-14 |
Results: 14
LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S NAUCKE S MATTOX S BRACY D CROWLEY J TRICOT G ALEXANIAN R
Citation: B. Barlogie et al., LONG-TERM FOLLOW-UP AFTER HIGH-DOSE THERAPY FOR HIGH-RISK MULTIPLE-MYELOMA, Bone marrow transplantation, 21(11), 1998, pp. 1101-1107
TREATMENT OF AL-AMYLOIDOSIS WITH DEXAMETHASONE PLUS ALPHA-INTERFERON
Authors: DHODAPKAR MV JAGANNATH S VESOLE D MUNSHI N NAUCKE S TRICOT G BARLOGIE B
Citation: Mv. Dhodapkar et al., TREATMENT OF AL-AMYLOIDOSIS WITH DEXAMETHASONE PLUS ALPHA-INTERFERON, Leukemia & lymphoma, 27(3-4), 1997, pp. 351-356
UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS
Authors: TRICOT G SAWYER JR JAGANNATH S DESIKAN KR SIEGEL D NAUCKE S MATTOX S BRACY D MUNSHI N BARLOGIE B
Citation: G. Tricot et al., UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS, Journal of clinical oncology, 15(7), 1997, pp. 2659-2666
BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT)
Authors: WALDRON J JAZIEH R JAGANNATH S DESIKAN KR SIEGEL D FASSAS A SINGHAL S MEHTA J TRICOT G VESOLE D WILSON C HOUGH A NAUCKE S SPOON D BARLOGIE B
Citation: J. Waldron et al., BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT), Blood, 90(10), 1997, pp. 394-394
FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S VESOLE D SIEGEL D DESIKAN KR MUNSHI N FASSAS A SINGHAL S MEHTA J SPOON D TRICOT G EVANS T NAUCKE S TINDLE S NELSON J COPELAND N BARLOGIE B
Citation: S. Jagannath et al., FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 1860-1860
SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA
Authors: BARLOGIE B JAGANNATH S VESOLE DH NAUCKE S CHESON B MATTOX S BRACY D SALMON S JACOBSON J CROWLEY J TRICOT G
Citation: B. Barlogie et al., SUPERIORITY OF TANDEM AUTOLOGOUS TRANSPLANTATION OVER STANDARD THERAPY FOR PREVIOUSLY UNTREATED MULTIPLE-MYELOMA, Blood, 89(3), 1997, pp. 789-793
20-PERCENT 9 YEAR SURVIVAL AFTER HIGH-DOSE THERAPY (HDT)+ -ABMT FOR HIGH-RISK MYELOMA (MM)LESS-THAN-OR-EQUAL-TO-AGE-50 OR B2M-LESS-THAN-OR-EQUAL-TO-2.5 MG/L PRE-HDT/
Authors: JAGANNATH S TRICOT G DESIKAN KR NAUCKE S MATTOX S DICKE K BARLOGIE B
Citation: S. Jagannath et al., 20-PERCENT 9 YEAR SURVIVAL AFTER HIGH-DOSE THERAPY (HDT)+ -ABMT FOR HIGH-RISK MYELOMA (MM)LESS-THAN-OR-EQUAL-TO-AGE-50 OR B2M-LESS-THAN-OR-EQUAL-TO-2.5 MG/L PRE-HDT/, Blood, 88(10), 1996, pp. 509-509
BOTH TRANSLOCATIONS AND 11 13 ABNORMALITIES HAVE A DOMINANT PROGNOSTIC IMPLICATION AND PREDICT POOR OUTCOME IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) TREATED WITH HIGH-DOSE THERAPY AND AUTOTRANSPLANTS (AT)/
Authors: TRICOT G BARLOGIE B JAGANNATH S DESIKAN KR SIEGEL D BRACY D MATTOX S NAUCKE S MUNSHI N SAWYER J
Citation: G. Tricot et al., BOTH TRANSLOCATIONS AND 11 13 ABNORMALITIES HAVE A DOMINANT PROGNOSTIC IMPLICATION AND PREDICT POOR OUTCOME IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) TREATED WITH HIGH-DOSE THERAPY AND AUTOTRANSPLANTS (AT)/, Blood, 88(10), 1996, pp. 1539-1539
TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS (2-TX) FOR 231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S TRICOT G VESOLE D DESIKAN KR MUNSHI N SIEGEL D CROWLEY J BRACY D MATTOX S NAUCKE S BARLOGIE B
Citation: S. Jagannath et al., TOTAL THERAPY (TT) WITH TANDEM AUTOTRANSPLANTS (2-TX) FOR 231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 2728-2728
POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES
Authors: TRICOT G SAWYER J JAGANNATH S BRACY D MATTOX S VESOLE DH NAUCKE S BARLOGIE B
Citation: G. Tricot et al., POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES, Experimental hematology, 23(8), 1995, pp. 867-867
POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES
Authors: TRICOT G BARLOGIE B JAGANNATH S BRACY D MATTER S VESOLE DH NAUCKE S SAWYER JR
Citation: G. Tricot et al., POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL ORCOMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES, Blood, 86(11), 1995, pp. 4250-4256
EFFICACY OF PULSE DEXAMETHASONE (DEX) PLUS MAINTENANCE ALPHA-INTERFERON (IFN) IN PRIMARY SYSTEMIC AMYLOIDOSIS (AL)
Authors: DHODAPKAR M JAGANNATH S VESOLE D TRICOT G MUNSHI N NAUCKE S BARLOGIE B
Citation: M. Dhodapkar et al., EFFICACY OF PULSE DEXAMETHASONE (DEX) PLUS MAINTENANCE ALPHA-INTERFERON (IFN) IN PRIMARY SYSTEMIC AMYLOIDOSIS (AL), Blood, 86(10), 1995, pp. 1756-1756
DOUBLE AUTOTRANSPLANTS CAN INDUCE MOLECULAR REMISSIONS (MCR) IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: TRICOT G BARLOGIE B JAGANNATH S VESOLE D NAUCKE S TIAN E GAZITT Y
Citation: G. Tricot et al., DOUBLE AUTOTRANSPLANTS CAN INDUCE MOLECULAR REMISSIONS (MCR) IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 86(10), 1995, pp. 3863-3863
TOTAL THERAPY (TT) FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM)
Authors: BARLOGIE B JAGANNATH S VESOLE D TRICOT G NAUCKE S COPELAND N CROWLEY J
Citation: B. Barlogie et al., TOTAL THERAPY (TT) FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM), Blood, 82(10), 1993, pp. 10000198-10000198
Risultati: 1-14 |